Eric M. Dube, CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc. (TVTX), sold 240,000 shares at $30.38 ($7.3M) on 2025-10-28, disclosed to the SEC on 2025-10-30.
Scheduled sale ($7.3M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.38 | 92,872 | $2.8M | 38.8% |
| 2 | $30.38 | 92,872 | $2.8M | 38.8% |
| 3 | $30.12 | 27,128 | $817K | 11.2% |
| 4 | $30.12 | 27,128 | $817K | 11.2% |
| Total | $30.32 avg | 240,000 | $7.3M | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |